91 – 100 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
- Contribution to journal › Article
-
Mark
Orexin and psychiatric symptoms in suicide attempters.
- Contribution to journal › Article
- 2006
-
Mark
Laminin {alpha}1 chain improves laminin {alpha}2 chain deficient peripheral neuropathy.
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
- Contribution to journal › Letter
-
Mark
Hypothalamic-endocrine aspects in Huntington's disease.
- Contribution to journal › Scientific review
-
Mark
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
- Contribution to journal › Article
-
Mark
Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat
- Contribution to journal › Article
- 2005
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
- Contribution to journal › Article
-
Mark
Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease.
- Contribution to journal › Article
-
Mark
Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.
- Contribution to journal › Article
